Skip to main content
Veterinary Medicines

Solupred 62,5 mg/ml Lyophilisat und Lösungsmittel zur Herstellung einer Injektionslösung für Hunde und Katzen

Authorised
  • Methylprednisolone hydrogen succinate

Product identification

Medicine name:
Solupred 62,5 mg/ml Lyophilisat und Lösungsmittel zur Herstellung einer Injektionslösung für Hunde und Katzen
Active substance:
  • Methylprednisolone hydrogen succinate
Target species:
  • Dog
  • Cat
Route of administration:
  • Intravenous use
  • Intramuscular use

Product details

Active substance and strength:
  • Methylprednisolone hydrogen succinate
    79.20
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Dog
    • Cat
  • Intramuscular use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02AB04
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • CP-Pharma Handelsgesellschaft mbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402281.00.00
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 15/01/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 15/01/2025

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 15/01/2025

2402281-parde-20170314.pdf

German (PDF)
Published on: 23/09/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."